Law ❯Securities Law ❯Securities Class Action Lawsuit ❯Amylyx Pharmaceuticals Lawsuit

False and Misleading Statements

Amylyx Pharmaceuticals Faces Multiple Securities Fraud Lawsuits

Investors allege misleading statements regarding ALS treatment RELYVRIO's commercial prospects and prescription rates.